Characteristic Features of SARS CoV-2
DOI:
https://doi.org/10.51985/FNWG4302Keywords:
Asymptomatic carrier, Corona virus, HCOV, RT-PCRAbstract
Corona-virus arose from China, spread globally and has become a great challenge for health care workers and Governments
of several countries. This virus is transmitted predominately through respiratory droplets by symptomatic and asymptomatic
carriers. The disease manifests itself with fever, dry cough and shortness of breath, these symptoms may be mild or have
fatal outcomes. This virus attaches to the angiotensin converting enzyme (ACE) receptor, in the lung. This assessment,
recapitulates the existing awareness of host features and the paths that are activated with HCOV (Human Corona virus)
infection highlighting the infection derived stress response, autophagy, apoptosis and natural defense mechanism. The
interaction of virulence tactics utilized by HCOV is also reviewed. This virus can be detected in the laboratory with help
of reverse transcription polymerase chain reaction (RT-PCR), with up to 50%-69% false negative results. Treatment agenda
is supportive therapy including supplemental oxygen, antipyretic, dexamethasone and ventilators.
References
Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli
R. Features, evaluation and treatment coronavirus (COVID-
. Stat. Pearls (2020). Publishing.[Google Scholar].
http://www.ncbi.nlm.nih.gov/books/NBK554776
Zhu N, Zhang D, Wang W, et al. A novel coronavirus from
patients with pneumonia in China, 2019. NEJM. 2020. DOI:
1056/NEJMoa2001017
Hui DS, Zumla A. Severe acute respiratory syndrome:
historical, epidemiologic, and clinical features. Infect Dis
Clin. 2019; 33(4):869-89. doi: 10.1016/j.idc.2019.07.001
Flaxman S, Mishra S, Gandy A, et al, Imperial College
COVID-19 Response Team. Estimating the effects of nonpharmaceutical
interventions on COVID-19 in Europe. Nature.
; 584(7820):257-261.http: // doi.org/10.1038/s41586.020-
-7
Mailles A, Blanckaert K, Chaud P, et al.First cases of Middle
East Respiratory Syndrome Coronavirus (MERS-CoV)
infections in France, investigations and implications for the
prevention of human-to-human transmission, France, 2013.
Euro surveillance. 2013; 18(24):20502. DOI: 10.2807/ese.
24.20502-en · Source: PubMed
Wu F, Zhao S, Yu B, et al. A new coronavirus associated with
human respiratory disease in China. Nature. 2020;
(7798):265-9. DOI:10.1038/s41586-020-2008-3
Kirchdoerfer RN, Cottrell CA, Wang N, et al. Pre-fusion
structure of a human coronavirus spike protein. Nature. 2016;
(7592):118-21. DOI: 10.1038/nature17200
Zheng J, Yamada Y, Fung TS, et al. Identification of N-linked
glycosylation sites in the spike protein and their functional
impact on the replication and infectivity of coronavirus
infectious bronchitis virus in cell culture. Virology. 2018;
:65-74. DOI: 10.1016/j.virol.2017.10.003
Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-
associated with acute respiratory distress syndrome. The
Lancet respiratory medicine. 2020 1; 8(4):420-2. DOI:
1016/S2213-2600(20)30076-X
Dos Santos WG. Impact of virus genetic variability and host
immunity for the success of COVID-19 vaccines. Biomedicine
& Pharmacotherapy. 2021:111272. DOI: 10.1016/ j.biopha.
111272
Walensky RP, Walke HT, Fauci AS. SARS-CoV-2 Variants
of Concern in the United States—Challenges and
Opportunities. JAMA. 2021. doi:10.1001/jama.2021.2294
Chu DK, Akl EA, Duda S, et al. Physical distancing, face
masks, and eye protection to prevent person-to-person
transmission of SARS-CoV-2 and COVID-19: a systematic
review and meta-analysis. The Lancet. 2020; 395(1024).
DOI:https://doi.org/10.1016/S0140-6736(20)31142-9Dashraath P, Wong JLJ, Lim MXK, etal. Coronavirus disease
(COVID-19) pandemicand pregnancy. Am J Obstet
Gynecol. 2020; 222(6):521-531. doi:10.1016/j.ajog.
03.021 doi: 10.1016/j.ajog.2020.03.021
Van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol
and surface stability SARS CoV-2 as compared with SARSCoV-
N Engl J Med. 2020; 382(16):1564-1567 DOI:
1056/NEJMc2004973.
Chia PY, Coleman KK, Tan YK, et al; Singapore2019 Novel
Coronavirus Outbreak Research Team. Detection of air and
surface contamination by SARS-CoV-2 in hospital rooms of
infected patients. NatCommun. 2020; 11(1):2800
doi.org/10.1038/s41467-020-16670-2/www.nature.com/
naturecommunications
Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott
HC. Pathophysiology, transmission, diagnosis, and treatment
of coronavirus disease 2019 (COVID-19): a review. Jama.
; 324(8):782-93. doi:10.1001/jama.2020.12839
World Health Organization. Coronavirus disease (COVID-
: weekly epidemiological update2020. https/iris/handle/
/333905
Xu XK, Liu XF, Wu Y, et al. Reconstruction of transmission
pairs for novel coronavirus disease 2019 (COVID-19) in
mainland China: estimation of super-spreading events, serial
interval, and hazard of infection. Clinical Infectious Diseases.
DOI: 10.1093/cid/ciaa790
Sarwar S, Waheed R, Sarwar S, Khan A. COVID-19 challenges
to Pakistan: Is GIS analysis useful to draw solutions? Science
of the Total Environment. 2020:139089. doi: 10.1016/j.
scitotenv.2020.139089
Hong KH, Lee SW, Kim TS, et al. Guidelines forlaboratory
diagnosis of coronavirus disease 2019 (COVID-19) in Korea.
Ann Lab Med 2020 ;40(5):351–60 DOI: 10.3343/alm.
40.5.351
Tahamtan A, Ardebili A. Real-time RT-PCR in COVID-19
detection: issues affecting the results.2020. doi:
1080/14737159.2020.1757437.
Loeffelhalz Mj, Tang YW, Laboratory diagnosis of emerging
human coronavirus infections-the state of the art Emerg
Microbe. Infect, 2020; 9: 747-56. DOI: 10.1080/22221751
.2020.1745095
Yamayoshi S, Sakai-Tagawa Y, Koga M, et al. Comparison
of Rapid Antigen Tests for COVID-19. Viruses. 2020;
(12):1420. DOI: 10.3390/v12121420
Vieira AL, PazeliJúnior JM, Kwee TC, Kwee RM. Chest CT
in COVID-19: what the radiologist needs to know.
RadioGraphics. 2020; 40(7):1848-65. https://doi.org/10.1148
/rg.2020200159
Bastos MG. Role of point-of-care ultrasound during the
COVID-19 pandemic: our recommendations in the
management of dialytic patients. The Ultrasound Journal.
; 12:1-9. doi: 10.1186/s13089-020-00177-4
Hassan SA, Sheikh FN, Jamal S, Ezeh JK, Akhtar A.
Coronavirus (COVID-19): a review of clinical features,
diagnosis, and treatment. Cureus. 2020; 12(3). DOI: 10.7759/
cureus.7355
Wu CN, Xia LZ, Li KH, et al. High-flow nasal-oxygenationassisted
fibreoptic tracheal intubation in critically ill patients
with COVID-19 pneumonia: a prospective randomised
controlled trial. BJA: British Journal of Anaesthesia. 2020.
DOI: 10.1016/j.bja.2020.02.02028. Hui DS, Chow BK, Lo T, et al. Exhaled air dispersion during
high-flow nasal cannula therapy versus CPAP via different
masks. European Respiratory Journal. 2019; 53(4):1802339.
DOI: 10.1183/13993003.02339-2018
Salmorán HO, Martínez IM, Greene EJ. Mechanical ventilation
in patients with COVID-19 according to Gattinoni phenotypes.
Acta Médica Grupo Ángeles. 2020; 18(3):336-40. Doi:
35366/95421
Ledford H. Coronavirus breakthrough: dexamethasone is first
drug shown to save lives. Nature. 2020; 582(7813):469. doi:
1038/d41586-020-01824-5.
Cao B, Wang Y, Wen D, et al. A trial of lopinavir–ritonavir
in adults hospitalized with severe Covid-19. NEJM. 2020.
DOI: 10.1056/NEJMoa2001282
Williamson BN, Feldmann F, Schwarz B, et al. Clinical benefit
of remdesivir in rhesus macaques infected with SARS-CoV-
BioRxiv. 2020. doi: https://doi.org/10.1101/ 2020.
15.043166
Gautret P, Lagier JC, Parola P,et al. Hydroxychloroquine and
azithromycin as a treatment of COVID-19: results of an openlabel
non-randomized clinical trial. Int J Antimicrob Agents.
; 56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949.34. Stewart K, Connelly D, and Robinson J. Everything you
should know about the coronavirus outbreak. The
Pharmaceutical Journal. 2020. :DOI:10.1211/ PJ.2021.
Buonaguro FM, Puzanov I, Ascierto PA. Anti-IL6R role in
treatment of COVID-19-related ARDS. J Transl Med. 2020;
(1):165. https://doi.org/10.1186/s12967-020-02333-9
Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy
of the BNT162b2 mRNA Covid-19 vaccine. ENJM. 2020;
(27):2603-15.
Livingston EH, Malani PN, Creech CB. The Johnson &
Johnson Vaccine for COVID-19. Jama. 2021; 325(15):1575-
. DOI: 10.1056/NEJMoa2034577
Kyriakidis NC, López-Cortés A, González EV, Grimaldos
AB, Prado EO. SARS-CoV-2 vaccines strategies: a
comprehensive review of phase 3 candidates. npj Vaccines.
; 6(1):1-7. doi: 10.1038/s41541-021-00292-w
Baraniuk C. Covid-19: What do we know about Sputnik V
and other Russian vaccines? bmj. 2021 19; 372. doi:
https://doi.org/10.1136/bmj.n743
Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety
of the mRNA-1273 SARS-CoV-2 vaccine. New England
Journal of Medicine. 2021; 384(5):403-16. DOI:
1056/NEJMoa2035389
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Shaista Bakhat, Yasmeen Taj
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0 
